1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Lymphocyte Turnover HIV-infected Patients Receiving Intermittent IL-2 - HIV Infection, Hepatitis C Infection & Antiretroviral Therapy"}],["$","meta","1",{"name":"description","content":"NIH Clinical Center Grand Rounds\n

\nLymphocyte Turnover in HIV-infected Patients Receiving Intermittent IL-2 Therapy: Insights From In Vivo Labeling Studies\n
\nJoseph A. Kovacs, M.D.\n
\nSenior Investigator and Head, AIDS Section, Critical Care Medicine Department, CC\n
\n
\nHIV Infection, Hepatitis C Infection and Antiretroviral Therapy: The Perfect Storm\n
\nShyam Kottilil, M.D., Ph.D.
\nStaff Clinician, Immunopathogenesis Section, NIAID\n
\n
\nFor more information, visit
\nhttp://clinicalcenter.nih.gov/about/news/grcurrent.shtml
"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Lymphocyte Turnover HIV-infected Patients Receiving Intermittent IL-2 - HIV Infection, Hepatitis C Infection & Antiretroviral Therapy"}],["$","meta","4",{"property":"og:description","content":"NIH Clinical Center Grand Rounds\n

\nLymphocyte Turnover in HIV-infected Patients Receiving Intermittent IL-2 Therapy: Insights From In Vivo Labeling Studies\n
\nJoseph A. Kovacs, M.D.\n
\nSenior Investigator and Head, AIDS Section, Critical Care Medicine Department, CC\n
\n
\nHIV Infection, Hepatitis C Infection and Antiretroviral Therapy: The Perfect Storm\n
\nShyam Kottilil, M.D., Ph.D.
\nStaff Clinician, Immunopathogenesis Section, NIAID\n
\n
\nFor more information, visit
\nhttp://clinicalcenter.nih.gov/about/news/grcurrent.shtml
"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/9822484f-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/d81a4284-31ee-4398-90f2-abb655be1a00.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Lymphocyte Turnover HIV-infected Patients Receiving Intermittent IL-2 - HIV Infection, Hepatitis C Infection & Antiretroviral Therapy"}],["$","meta","11",{"name":"twitter:description","content":"NIH Clinical Center Grand Rounds\n

\nLymphocyte Turnover in HIV-infected Patients Receiving Intermittent IL-2 Therapy: Insights From In Vivo Labeling Studies\n
\nJoseph A. Kovacs, M.D.\n
\nSenior Investigator and Head, AIDS Section, Critical Care Medicine Department, CC\n
\n
\nHIV Infection, Hepatitis C Infection and Antiretroviral Therapy: The Perfect Storm\n
\nShyam Kottilil, M.D., Ph.D.
\nStaff Clinician, Immunopathogenesis Section, NIAID\n
\n
\nFor more information, visit
\nhttp://clinicalcenter.nih.gov/about/news/grcurrent.shtml
"}],["$","meta","12",{"name":"twitter:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/d81a4284-31ee-4398-90f2-abb655be1a00.jpg"}],["$","link","13",{"rel":"icon","href":"/favicon.ico","type":"image/x-icon","sizes":"512x512"}],"$L22"],"error":null,"digest":"$undefined"}